1
|
Alldredge CT, Sliwinski JR, Elkins GR. Treating Hot Flashes with Hypnosis: Does Hypnotizability Modulate Reductions? J Clin Psychol Med Settings 2024; 31:465-470. [PMID: 38265698 DOI: 10.1007/s10880-023-09994-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/05/2023] [Indexed: 01/25/2024]
Abstract
Hypnosis is an effective treatment option for a variety of concerns. Past research has suggested that those who score in the high range of hypnotizability initially show greater improvement than those in the low range. A post hoc analysis was conducted to examine the extent to which hypnotizability modulates the reduction of hot flash frequency. Average number of hot flashes reported during hypnosis treatment and a 12-week follow-up were grouped according to participants' level of hypnotizability. Using baseline data, the reduction percentage of hot flash frequency was plotted and visually examined to determine when a clinically significant reduction (50%) in hot flashes was reached. Our results suggested that, regardless of hypnotizability, participants ultimately obtained a 50% reduction in hot flash frequency. Interestingly, participants who were rated as either moderately or highly hypnotizable achieved a 50% reduction by Week 3 while those of low hypnotizability did not cross the 50% reduction threshold until the 12-week follow-up. Implications from these findings include the importance of assessing hypnotizability in clinical settings to better tailor treatment dose and expectations.
Collapse
Affiliation(s)
- Cameron T Alldredge
- Department of Psychology and Neuroscience, Baylor University, 801 Washington Ave., 2nd Floor, Waco, TX, 76701, USA.
| | - Jim R Sliwinski
- Department of Psychology, Defiance College, Defiance, OH, USA
| | - Gary R Elkins
- Department of Psychology and Neuroscience, Baylor University, 801 Washington Ave., 2nd Floor, Waco, TX, 76701, USA
| |
Collapse
|
2
|
Siewert J, Teut M, Brinkhaus B, Fisch S, Kummer S. The relevance of outcome expectations in group hypnosis for stress reduction: a secondary analysis of a multicenter randomized controlled trial. Front Psychol 2024; 15:1363037. [PMID: 38708017 PMCID: PMC11069319 DOI: 10.3389/fpsyg.2024.1363037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2023] [Accepted: 04/09/2024] [Indexed: 05/07/2024] Open
Abstract
Background There is evidence that patients' positive outcome expectations prior to study interventions are associated with better treatment outcomes. Nevertheless, to date, only few studies have investigated whether individual outcome expectations affect treatment outcomes in hypnosis. Objective To examine whether outcome expectations to hypnosis prior to starting treatment were able to predict perceived stress, as measured on a visual analog scale (VAS), after 5 weeks. Methods We performed a secondary data analysis of a multicenter randomized controlled trial of intervention group participants only. Study participants with stress symptoms were randomized to 5 weekly sessions of a group hypnosis program for stress reduction and improved stress coping, plus 5 hypnosis audio recordings for further individual practice at home, as well as an educational booklet on coping with stress. Perceived stress for the following week was measured at baseline and after 5 weeks using a visual analog scale (0-100 mm; VAS). Hypnosis outcome expectations were assessed at baseline only with the Expectations for Treatment Scale (ETS). Unadjusted and adjusted linear regressions were performed to examine the association between baseline expectations and perceived stress at 5 weeks. Results Data from 47 participants (M = 45.02, SD = 13.40 years; 85.1% female) were analyzed. Unadjusted (B = 0.326, t = 0.239, p = 0.812, R2 = 0.001) and adjusted (B = 0.639, t = 0.470, p = 0.641, R2 = 0.168) linear regressions found that outcome expectations to hypnosis were not associated with a change in perceived stress between baseline and after 5 weeks in the intervention group. Conclusion Our findings suggest that the beneficial effect of group hypnosis in distressed participants were not associated with outcome expectations. Other mechanisms of action may be more important for the effect of hypnosis, which should be explored in future research.Clinical trial registration: ClinicalTrials.gov, identifier NCT03525093.
Collapse
Affiliation(s)
- Julia Siewert
- Institute of Social Medicine, Epidemiology and Health Economics, Charité – Universitätsmedizin Berlin, Berlin, Germany
| | - Michael Teut
- Institute of Social Medicine, Epidemiology and Health Economics, Charité – Universitätsmedizin Berlin, Berlin, Germany
| | - Benno Brinkhaus
- Institute of Social Medicine, Epidemiology and Health Economics, Charité – Universitätsmedizin Berlin, Berlin, Germany
| | - Silvia Fisch
- Psychotherapie-Praxis Kupferstraße, Coesfeld, Germany
| | - Sonja Kummer
- Institute of Social Medicine, Epidemiology and Health Economics, Charité – Universitätsmedizin Berlin, Berlin, Germany
| |
Collapse
|
3
|
Kekecs Z, Nyiri B, Alldredge C, Cserni B, Rizzo P, Domok B, Vizkievicz V, Takacs A, Giran K, Nagy JK, Elkins G. The Effectiveness of Hypnoanalgesia Using Conventional and Placebo Hypnosis Induction. THE JOURNAL OF PAIN 2024:104519. [PMID: 38582287 DOI: 10.1016/j.jpain.2024.03.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/12/2024] [Revised: 03/27/2024] [Accepted: 03/29/2024] [Indexed: 04/08/2024]
Abstract
The effectiveness of hypnosis-based pain management is well-established. However, mechanisms of action and specific effective components are not well understood. The sociocognitive theory of hypnosis proposes that the effectiveness of hypnosis for pain management is determined by the nonspecific features of response expectancy and context. We tested this claim by contrasting the effectiveness of 2 hypnoanalgesia procedures in a within subjects design using the cold pressor task. The 2 procedures were identical, including analgesic suggestions, except for the hypnosis induction used. One condition involved a well-established hypnosis induction, including suggestions for focused attention, relaxation, and deepening. The other condition included a sham induction procedure using only white noise. In our confirmatory analysis (N = 46), we found that pain tolerance increased compared to baseline equivalently in the conventional and sham induction conditions (mean increase 13.7 and 12.4 seconds respectively, average within subject difference -1.27 seconds, 90% confidence interval [CI] = -8.46, 5.90). This finding supports the claim of the sociocognitive theory considering that response expectancy for pain reduction was also equivalent between the conditions (average difference 2.30, 90% CI = -2.23, 6.84). However, self-reported hypnosis depth was greater in the conventional induction condition (average difference -.78, 90% CI: -1.36, -.07), which contradicts sociocognitive predictions. Our findings indicate that conventional procedural elements of hypnosis inductions, such as suggestions for focused attention, relaxation, and deepening, may not be necessary to achieve acute pain reduction in an experimental setting when the hypnosis intervention includes analgesic suggestions. PERSPECTIVE: This study assessed the necessary effective components of hypnosis-based analgesia interventions. Our findings suggest that procedural features such as suggestions for focused attention, relaxation, and deepening may not be necessary for hypnoanalgesia as long as pain relief suggestions are present, and the hypnosis context and response expectancy are established. TRIAL REGISTRATION: This trial was registered on Open Science Framework with the registry number e96xk, available at https://osf.io/e96xk.
Collapse
Affiliation(s)
| | - Balazs Nyiri
- Psychology Doctoral Program, ELTE, Budapest, Hungary
| | - Cameron Alldredge
- Department of Psychology and Neuroscience, Baylor University, Waco, Texas
| | | | - Pietro Rizzo
- Psychology, Master of Science Program, Lund University, Lund, Sweden
| | | | | | - Aliz Takacs
- Psychology MA Program, ELTE, Budapest, Hungary
| | - Kyra Giran
- Psychology MA Program, ELTE, Budapest, Hungary
| | | | - Gary Elkins
- Department of Psychology and Neuroscience, Baylor University, Waco, Texas
| |
Collapse
|
4
|
Abstract
OBJECTIVE To update the evidence-based Nonhormonal Management of Menopause-Associated Vasomotor Symptoms: 2015 Position Statement of The North American Menopause Society. METHODS An advisory panel of clinicians and research experts in women's health were selected to review and evaluate the literature published since the Nonhormonal Management of Menopause-Associated Vasomotor Symptoms: 2015 Position Statement of The North American Menopause Society. Topics were divided into five sections for ease of review: lifestyle; mind-body techniques; prescription therapies; dietary supplements; and acupuncture, other treatments, and technologies. The panel assessed the most current and available literature to determine whether to recommend or not recommend use based on these levels of evidence: Level I, good and consistent scientific evidence; Level II, limited or inconsistent scientific evidence, and Level III, consensus and expert opinion. RESULTS Evidence-based review of the literature resulted in several nonhormone options for the treatment of vasomotor symptoms. Recommended: Cognitive-behavioral therapy, clinical hypnosis, selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors, gabapentin, fezolinetant (Level I); oxybutynin (Levels I-II); weight loss, stellate ganglion block (Levels II-III). Not recommended: Paced respiration (Level I); supplements/herbal remedies (Levels I-II); cooling techniques, avoiding triggers, exercise, yoga, mindfulness-based intervention, relaxation, suvorexant, soy foods and soy extracts, soy metabolite equol, cannabinoids, acupuncture, calibration of neural oscillations (Level II); chiropractic interventions, clonidine; (Levels I-III); dietary modification and pregabalin (Level III). CONCLUSION Hormone therapy remains the most effective treatment for vasomotor symptoms and should be considered in menopausal women within 10 years of their final menstrual periods. For women who are not good candidates for hormone therapy because of contraindications (eg, estrogen-dependent cancers or cardiovascular disease) or personal preference, it is important for healthcare professionals to be well informed about nonhormone treatment options for reducing vasomotor symptoms that are supported by the evidence.
Collapse
|
5
|
Abstract
The absence of a Spanish translation of the Elkins Hypnotizability Scale (EHS) suggests access to clinical research and hypnotic interventions may be limited for those in predominantly Spanish-speaking populations. The present study aims to mitigate this disparity by providing a translation of the EHS to facilitate participation in experimental research and clinical care in Spanish-speaking communities. The EHS was translated and administered to 9 participants. No major modifications were done to the characteristics or structure of the EHS after translation. To assess feasibility, mean hypnotizability levels and self-reported levels of pleasantness and comprehension were observed and compared to the English EHS. The results provide a Spanish translation of the EHS. This study demonstrates the Spanish translation of the EHS is feasible for further research.
Collapse
Affiliation(s)
- Vanessa Muñiz
- Department of Psychology and Neuroscience, Baylor University, Waco, Texas, USA
| | - Morgan Snyder
- Department of Psychology and Neuroscience, Baylor University, Waco, Texas, USA
| | - Gary R Elkins
- Department of Psychology and Neuroscience, Baylor University, Waco, Texas, USA
| |
Collapse
|
6
|
Arbour C, Tremblay M, Ogez D, Martineau-Lessard C, Lavigne G, Rainville P. Feasibility and acceptability of hypnosis-derived communication administered by trained nurses to improve patient well-being during outpatient chemotherapy: a pilot-controlled trial. Support Care Cancer 2021; 30:765-773. [PMID: 34374847 PMCID: PMC8636401 DOI: 10.1007/s00520-021-06481-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2021] [Accepted: 07/28/2021] [Indexed: 12/25/2022]
Abstract
Purpose This pilot-controlled trial aimed to examine the feasibility and acceptability of hypnosis-derived communication (HC) administered by trained nurses during outpatient chemotherapy to optimize symptom management and emotional support — two important aspects of patient well-being in oncology. Methods The trial was conducted in two outpatient oncology units: (1) intervention site (usual care with HC), and (2) control site (usual care). Nurses at the intervention site were invited to take part in an 8-h training in HC. Participants’ self-ratings of symptoms and emotional support were gathered at predetermined time points during three consecutive outpatient visits using the Edmonton Symptom Assessment Scale and the Emotional Support Scale. Results Forty-nine patients (24 in the intervention group, 25 in the control group) with different cancer types/stages were recruited over a period of 3 weeks and completed the study. All nurses (N = 10) at the intervention site volunteered to complete the training and were able to include HC into their chemotherapy protocols (about ± 5 min/intervention). Compared to usual care, patients exposed to HC showed a significant reduction in physical symptoms during chemotherapy. In contrast, perception of emotional support did not show any significant effect of the intervention. Participants exposed to HC report that the intervention helped them relax and connect on a more personal level with the nurse during chemotherapy infusion. Conclusions Our results suggest that HC is feasible, acceptable, and beneficial for symptom management during outpatient chemotherapy. While future studies are needed, hypnosis techniques could facilitate meaningful contacts between cancer patients and clinicians in oncology. Trial registration Clinical Trial Identifier: NCT04173195, first posted on November 19, 2019 Supplementary Information The online version contains supplementary material available at 10.1007/s00520-021-06481-6.
Collapse
Affiliation(s)
- Caroline Arbour
- Hôpital du Sacré-Cœur de Montréal, CIUSSS du Nord-de-L'Île-de-Montréal, 5400 Boul. Gouin Ouest, Room: E-1381, Montreal, QC, H4J 1C5, Canada. .,Faculty of Nursing, Université de Montréal, Montreal, QC, Canada.
| | - Marjorie Tremblay
- Hôpital de La Cité-de-La-Santé, CISSS de Laval, Laval, QC, Canada.,Faculty of Medicine, Université de Montréal, Montreal, QC, Canada
| | - David Ogez
- Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.,Centre de Recherche de L'Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada
| | - Chloé Martineau-Lessard
- Hôpital du Sacré-Cœur de Montréal, CIUSSS du Nord-de-L'Île-de-Montréal, 5400 Boul. Gouin Ouest, Room: E-1381, Montreal, QC, H4J 1C5, Canada.,Faculty of Medicine, Université de Montréal, Montreal, QC, Canada
| | - Gilles Lavigne
- Hôpital du Sacré-Cœur de Montréal, CIUSSS du Nord-de-L'Île-de-Montréal, 5400 Boul. Gouin Ouest, Room: E-1381, Montreal, QC, H4J 1C5, Canada.,Faculty of Dental Medicine, Université de Montréal, Montreal, QC, Canada
| | - Pierre Rainville
- Faculty of Dental Medicine, Université de Montréal, Montreal, QC, Canada.,Institut Universitaire de Gériatrie de Montréal, CIUSSS du Centre-Sud-de-L'Île-de-Montréal, Montreal, QC, Canada
| |
Collapse
|